Literature DB >> 9377137

Hepatitis B vaccination in preterm infants.

F Y Huang1, P I Lee, C Y Lee, L M Huang, L Y Chang, S C Liu.   

Abstract

AIM: To investigate the immunogenicity and safety of existing recommendations for hepatitis B vaccination in preterm infants.
METHODS: Recombinant hepatitis B vaccine (H-B-VAX II, 5 micrograms per dose) was given to 85 preterm infants divided into two groups, using two different schedules. Forty four group A infants with birthweights of < 2000 g received three doses at 1, 2, and 7 months of age. Forty one group B infants with birthweights of > or = 2000 g received three doses at 0, 1, and 6 months of age.
RESULTS: After vaccination, 42 infants from group A (95%) and 37 infants from group B (90%) developed protective levels of antibody. The final seropositive rate and the geometric mean concentration of hepatitis B surface antibody between the two groups were not significantly different. The immune response of preterm infants to hepatitis B vaccines was similar to that of term infants in a previous study.
CONCLUSIONS: Preterm infants can be given hepatitis B vaccines using one of the above two different schedules, at a cutoff birthweight of 2000 g.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9377137      PMCID: PMC1720692          DOI: 10.1136/fn.77.2.f135

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  15 in total

1.  Response of preterm infants to hepatitis B vaccine.

Authors:  Y L Lau; A Y Tam; K W Ng; N S Tsoi; B Lam; P Lam; C Y Yeung
Journal:  J Pediatr       Date:  1992-12       Impact factor: 4.406

2.  Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children.

Authors:  P I Lee; M H Chang; C Y Lee; H Y Hsu; J S Chen; P J Chen; D S Chen
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

3.  Vertical transmission of hepatitis B antigen in Taiwan.

Authors:  C E Stevens; R P Beasley; J Tsui; W C Lee
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

4.  Immune response to hepatitis B vaccine in premature neonates.

Authors:  S Chawareewong; A Jirapongsa; K Lokaphadhana
Journal:  Southeast Asian J Trop Med Public Health       Date:  1991-03       Impact factor: 0.267

5.  The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.

Authors:  C Y Lee; L M Huang; M H Chang; C Y Hsu; S J Wu; J L Sung; A Safary
Journal:  Pediatr Infect Dis J       Date:  1991-04       Impact factor: 2.129

6.  Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan.

Authors:  H L Chen; M H Chang; Y H Ni; H Y Hsu; P I Lee; C Y Lee; D S Chen
Journal:  JAMA       Date:  1996-09-18       Impact factor: 56.272

Review 7.  Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection.

Authors:  C E Stevens; P T Toy; P E Taylor; T Lee; H Y Yip
Journal:  Pediatrics       Date:  1992-07       Impact factor: 7.124

8.  Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.

Authors:  R P Beasley; L Y Hwang; G C Lee; C C Lan; C H Roan; F Y Huang; C L Chen
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

9.  A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers.

Authors:  D S Chen; N H Hsu; J L Sung; T C Hsu; S T Hsu; Y T Kuo; K J Lo; Y T Shih
Journal:  JAMA       Date:  1987-05-15       Impact factor: 56.272

10.  Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program.

Authors:  Y J Tsen; M H Chang; H Y Hsu; C Y Lee; J L Sung; D S Chen
Journal:  J Med Virol       Date:  1991-06       Impact factor: 2.327

View more
  6 in total

1.  Immunogenicity of plasma-derived hepatitis B vaccine in preterm infants.

Authors:  K R Shankar; R K Dhiman; A Narang
Journal:  Indian J Pediatr       Date:  2000-01       Impact factor: 1.967

Review 2.  Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability.

Authors:  Carl T D'Angio
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

3.  Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule.

Authors:  Ke Han; Xiaoping Shao; Huizhen Zheng; Chenggang Wu; Jianqiong Zhu; Xiaoli Zheng; Yonghui Zhang
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

4.  Hepatitis B response of premature infants after primary and booster immunisation with a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus/haemophilus influenzae type B vaccine.

Authors:  Felix Omeñaca; Jose Garcia-Sicilia; Reyes Boceta; Pilar García-Corbeira
Journal:  Infect Dis Obstet Gynecol       Date:  2010-04-12

5.  Weight-based policy of hepatitis B vaccination in very low birth weight infants in Taiwan: a retrospective cross-sectional study.

Authors:  Chien-Yi Chen; Huey-Ling Chen; Hung-Chieh Chou; Po-Nien Tsao; Wu-Shiun Hsieh; Mei-Hwei Chang
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

6.  Evaluation of immunogenicity after first dose of hepatitis B vaccine in newborns with very low birth weight.

Authors:  Sinan Tüfekci; Erhan Aygün; Hülya Halis
Journal:  Hum Vaccin Immunother       Date:  2021-07-21       Impact factor: 4.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.